Growth Retardation, Reduced Invasiveness, and Impaired Colistin-Mediated Cell Death Associated with Colistin Resistance Development in Acinetobacter baumannii
暂无分享,去创建一个
J. Hardouin | S. Pournaras | D. Makris | P. Cosette | A. Tsakris | Ioulia Kristo | A. Poulou | K. Dafopoulou | E. Dé | Y. Chabane
[1] R. López-Rojas,et al. Colistin Resistance in a Clinical Acinetobacter baumannii Strain Appearing after Colistin Treatment: Effect on Virulence and Bacterial Fitness , 2013, Antimicrobial Agents and Chemotherapy.
[2] B. Devreese,et al. A review on recent developments in mass spectrometry instrumentation and quantitative tools advancing bacterial proteomics , 2013, Applied Microbiology and Biotechnology.
[3] R. Humphries,et al. Colistin MIC Variability by Method for Contemporary Clinical Isolates of Multidrug-Resistant Gram-Negative Bacilli , 2013, Journal of Clinical Microbiology.
[4] N. Soares,et al. Extracellular proteome of a highly invasive multidrug-resistant clinical strain of Acinetobacter baumannii. , 2012, Journal of proteome research.
[5] M. Sanguinetti,et al. CspR, a Cold Shock RNA-Binding Protein Involved in the Long-Term Survival and the Virulence of Enterococcus faecalis , 2012, Journal of bacteriology.
[6] E. Burd,et al. Rapid Killing of Acinetobacter baumannii by Polymyxins Is Mediated by a Hydroxyl Radical Death Pathway , 2012, Antimicrobial Agents and Chemotherapy.
[7] Rui Wang,et al. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. , 2012, The Journal of antimicrobial chemotherapy.
[8] J. Pachón,et al. Attenuated virulence of a slow-growing pandrug-resistant Acinetobacter baumannii is associated with decreased expression of genes encoding the porins CarO and OprD-like. , 2011, International journal of antimicrobial agents.
[9] J. Vila,et al. Growth of Acinetobacter baumannii in Pellicle Enhanced the Expression of Potential Virulence Factors , 2011, PloS one.
[10] D. Raoult,et al. Acinetobacter baumannii resistant to colistin with impaired virulence: a case report from France. , 2011, The Journal of infectious diseases.
[11] K. Ko,et al. Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii. , 2011, International journal of antimicrobial agents.
[12] N. Woodford,et al. Phosphoethanolamine Modification of Lipid A in Colistin-Resistant Variants of Acinetobacter baumannii Mediated by the pmrAB Two-Component Regulatory System , 2011, Antimicrobial Agents and Chemotherapy.
[13] R. López-Rojas,et al. Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii. , 2011, The Journal of infectious diseases.
[14] Jian Li,et al. Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production , 2010, Antimicrobial Agents and Chemotherapy.
[15] L. Dijkshoorn,et al. The Population Structure of Acinetobacter baumannii: Expanding Multiresistant Clones from an Ancestral Susceptible Genetic Pool , 2010, PloS one.
[16] P. Higgins,et al. Global spread of carbapenem-resistant Acinetobacter baumannii. , 2010, The Journal of antimicrobial chemotherapy.
[17] S. Pournaras,et al. Heteroresistance to Meropenem in Carbapenem-Susceptible Acinetobacter baumannii , 2009, Journal of Clinical Microbiology.
[18] M. Adams,et al. Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System , 2009, Antimicrobial Agents and Chemotherapy.
[19] D. Andreu,et al. The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective , 2009, Proteomics.
[20] J. Pachón,et al. Nosocomial Outbreak of Infection With Pan–Drug-Resistant Acinetobacter baumannii in a Tertiary Care University Hospital , 2009, Infection Control & Hospital Epidemiology.
[21] J. Collins,et al. A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics , 2007, Cell.
[22] R. Bonomo,et al. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] A. Maniatis,et al. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit. , 2006, The Journal of antimicrobial chemotherapy.
[24] P. Fournier,et al. The epidemiology and control of Acinetobacter baumannii in health care facilities. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] G. Rossolini,et al. Novel Acquired Metallo-β-Lactamase Gene, blaSIM-1, in a Class 1 Integron from Acinetobacter baumannii Clinical Isolates from Korea , 2005, Antimicrobial Agents and Chemotherapy.
[26] P. Higgins,et al. Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii. , 2004, Journal of Antimicrobial Chemotherapy.
[27] Seungok Lee,et al. Prevalence of metallo-β-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii in a Korean University hospital and comparison of screening methods for detecting metallo-β-lactamase , 2003 .
[28] R. Hancock,et al. Peptide antibiotics , 1997, The Lancet.
[29] D H Persing,et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing , 1995, Journal of clinical microbiology.
[30] S. Pournaras,et al. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. , 2013, International journal of antimicrobial agents.
[31] U. Pennsylvania. Clinical and Laboratory Standards Institute. , 2013 .
[32] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .
[33] John A. Kellen,et al. Mechanisms of Multidrug Resistance , 1995 .